Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zuhal Eraslan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Handbook of Experimental Pharmacology|December 1, 2022
Metabolomics in Cell BiologyZuhal Eraslan, Marta Cascante, Ulrich L Günther
Cells|October 23, 2021
Targeting Asparagine and Serine Metabolism in Germinal Centre-Derived B Cells Non-Hodgkin Lymphomas (B-NHL)Zuhal Eraslan, Grigorios Papatzikas, Jean-Baptiste Cazier, et al.
Scientific Reports|February 23, 2019
A framework for tracer-based metabolism in mammalian cells by NMRRaquel Saborano, Zuhal Eraslan, Jennie Roberts, et al.
Pigment Cell & Melanoma Research|June 6, 2024
Two-pore channel 2 is required for soluble adenylyl cyclase-dependent regulation of melanosomal pH and melanin synthesisDalee Zhou, Zuhal Eraslan, Dawson Miller, et al.
Cell Reports|September 28, 2022
A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivationMarek M Drozdz, Ashley S Doane, Rached Alkallas, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Targeting melanosome pH is an effective method for the treatment of oculocutaneous albinismSamuel J Grondin, Daniela St Pierre, David J Green, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Ampyrone (4-Aminoantipyrine) is a Direct Agonist of Human Tyrosinase and Potential Therapeutic for Oculocutaneous Albinism and Disorders of HypopigmentationMonika B Dolinska, Yuhong Wang, Nathan P Coussens, et al.
JCI Insight|June 18, 2026
Ampyrone is a direct agonist of human tyrosinase and a potential therapeutic for hypopigmentation disordersMonika B Dolinska, Yuhong A Wang, Nathan P Coussens, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Handbook of Experimental Pharmacology|December 1, 2022
Metabolomics in Cell BiologyZuhal Eraslan, Marta Cascante, Ulrich L Günther
Cells|October 23, 2021
Targeting Asparagine and Serine Metabolism in Germinal Centre-Derived B Cells Non-Hodgkin Lymphomas (B-NHL)Zuhal Eraslan, Grigorios Papatzikas, Jean-Baptiste Cazier, et al.
Scientific Reports|February 23, 2019
A framework for tracer-based metabolism in mammalian cells by NMRRaquel Saborano, Zuhal Eraslan, Jennie Roberts, et al.
Pigment Cell & Melanoma Research|June 6, 2024
Two-pore channel 2 is required for soluble adenylyl cyclase-dependent regulation of melanosomal pH and melanin synthesisDalee Zhou, Zuhal Eraslan, Dawson Miller, et al.
Cell Reports|September 28, 2022
A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivationMarek M Drozdz, Ashley S Doane, Rached Alkallas, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Targeting melanosome pH is an effective method for the treatment of oculocutaneous albinismSamuel J Grondin, Daniela St Pierre, David J Green, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Ampyrone (4-Aminoantipyrine) is a Direct Agonist of Human Tyrosinase and Potential Therapeutic for Oculocutaneous Albinism and Disorders of HypopigmentationMonika B Dolinska, Yuhong Wang, Nathan P Coussens, et al.
JCI Insight|June 18, 2026
Ampyrone is a direct agonist of human tyrosinase and a potential therapeutic for hypopigmentation disordersMonika B Dolinska, Yuhong A Wang, Nathan P Coussens, et al.
Pageof 1